| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |